The Safety Profile of Upadacitinib in Japanese Patients with Rheumatoid Arthritis

被引：0
|
作者：
Yamaoka, Kunihiro [1 ]
Tanaka, Yoshiya [2 ]
Kameda, Hideto [3 ]
Hendrickson, Barbara [4 ]
Meerwein, Sebastian [5 ]
Zhang, Ying [4 ]
Takeuchi, Tsutomu [6 ]
机构：
[1] Kitasato Univ, Sch Med, Sagamihara, Kanagawa, Japan
[2] Univ Occupat & Environm Hlth Japan, Kitakyushu, Fukuoka, Japan
[3] Toho Univ, Tokyo, Japan
[4] AbbVie Inc, N Chicago, IL USA
[5] AbbVie GmbH Co KG, Ludwigshafen, Germany
[6] Keio Univ, Sch Med, Tokyo, Japan
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2407
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Safety Profile of Upadacitinib in Rheumatoid Arthritis: Integrated Analysis from the SELECT Phase 3 Clinical Program
    Cohen, Stanley
    van Vollenhoven, Ronald
    Winthrop, Kevin
    Zerbini, Cristiano A.
    Tanaka, Yoshiya
    Bessette, Louis
    Zhang, Ying
    Khan, Nasser
    Hendrickson, Barbara
    Enejosa, Jose Jeffrey
    Burmester, Gerd
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [32] Efficacy and safety of upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE): a placebo-controlled phase IIb/III study
    Kameda, Hideto
    Takeuchi, Tsutomu
    Yamaoka, Kunihiro
    Oribe, Motohiro
    Kawano, Mitsuhiro
    Zhou, Yijie
    Othman, Ahmed A.
    Pangan, Aileen L.
    Kitamura, Susumu
    Meerwein, Sebastian
    Tanaka, Yoshiya
    RHEUMATOLOGY, 2020, 59 (11) : 3303 - 3313
  • [33] Characterization of Serious Infections with Upadacitinib in Patients with Rheumatoid Arthritis
    Winthrop, Kevin
    Calabrese, Leonard
    Van den Bosch, Filip
    Yamaoka, Kunihiro
    Selmi, Carlo
    Song, Yanna
    Hendrickson, Barbara
    Lagunes-Galindo, Ivan
    McInnes, Iain
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [34] CHARACTERIZATION OF SERIOUS INFECTIONS WITH UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Winthrop, K.
    Calabrese, L.
    Van den Bosch, F.
    Yamaoka, K.
    Selmi, C.
    Song, Y.
    Hendrickson, B.
    Lagunes-Galindo, I.
    Mcinnes, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 650 - 651
  • [35] A review of upadacitinib in rheumatoid arthritis
    Tanaka, Yoshiya
    MODERN RHEUMATOLOGY, 2020, 30 (05) : 779 - 787
  • [36] Upadacitinib for the treatment of rheumatoid arthritis
    Serhal, Lina
    Edwards, Christopher J.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2019, 15 (01) : 13 - 25
  • [37] Upadacitinib tartrate in rheumatoid arthritis
    Stamatis, P.
    Bogdanos, D. P.
    Sakkas, L., I
    DRUGS OF TODAY, 2020, 56 (11) : 723 - 732
  • [38] EFFICACY AND SAFETY OF BARICITINIB IN JAPANESE RHEUMATOID ARTHRITIS PATIENTS AT 12 WEEKS
    Tanaka, Y.
    Emoto, K.
    Tsujimoto, M.
    Schlichting, D.
    Macias, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 231 - 231
  • [39] Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
    Koike, Takao
    Harigai, Masayoshi
    Inokuma, Shigeko
    Ishiguro, Naoki
    Ryu, Junnosuke
    Takeuchi, Tsutomu
    Tanaka, Yoshiya
    Yamanaka, Hisashi
    Fujii, Koichi
    Yoshinaga, Takunari
    Freundlich, Bruce
    Suzukawa, Michio
    MODERN RHEUMATOLOGY, 2011, 21 (04) : 343 - 351
  • [40] Efficacy and Safety of Adalimumab Therapy in Japanese Patients with Rheumatoid Arthritis.
    Hattori, Yosuke
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S219 - S220
12345